Apratoxin S4 Inspired by a Marine Natural Product, a New Treatment Option for Ocular Angiogenic Diseases

Investigative Ophthalmology & Visual Science
Beiying QiuXiaomeng Wang

Abstract

Abnormal blood vessel formation is a defining feature of many blinding eye diseases. Targeting abnormal angiogenesis by inhibiting VEGF has revolutionized the treatment of many ocular angiogenic diseases over the last decade. However, a substantial number of patients are refractory to anti-VEGF treatment or may develop resistance over time. The objective of this study was to determine the efficacy and the mechanism of action of Apratoxin S4 in ocular angiogenesis. Retinal vascular cell proliferation, migration, and the ability to form tube-like structure were studied in vitro. Ex vivo aortic ring, choroid, and metatarsal assays were used to study Apratoxin S4's impact on vessel outgrowth in a multicellular environment. Apratoxin S4 was also tested in mouse models of oxygen-induced retinopathy (OIR) and laser-induced choroidal neovascularization (CNV), and in a rabbit model of persistent retinal neovascularization (PRNV). Western blot and ELISA were used to determine the expression of key angiogenic regulators after Apratoxin S4 treatment. Apratoxin S4 strongly inhibits retinal vascular cell activation by suppressing multiple angiogenic pathways. VEGF-activated vascular cells and angiogenic vessels are more susceptible to Aprato...Continue Reading

References

Jan 20, 1999·Current Topics in Microbiology and Immunology·S Davis, G D Yancopoulos
Dec 6, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ralf ErberPeter Vajkoczy
Dec 17, 2004·Pharmacological Reviews·Ann HoebenErnst A De Bruijn
Sep 17, 2005·Circulation Research·Annika ArmulikChrister Betsholtz
Dec 16, 2005·Nature·Peter Carmeliet
Feb 14, 2006·Nature Chemical Biology·Hendrik LueschPeter G Schultz
Aug 28, 2007·Cell·Sunyoung LeeM Luisa Iruela-Arispe
May 17, 2008·Genes & Development·Johanna AndraeChrister Betsholtz
Jan 12, 2010·Journal of Burn Care & Research : Official Publication of the American Burn Association·Areck A UcuzianHoward P Greisler
Mar 3, 2011·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Jincai LuoYao Lu
Aug 24, 2011·Nature Reviews. Molecular Cell Biology·Shane P Herbert, Didier Y R Stainier
Jul 4, 2012·The American Journal of Pathology·Leo A Kim, Patricia A D'Amore
Jul 5, 2012·Cold Spring Harbor Perspectives in Medicine·Sina Koch, Lena Claesson-Welsh
Jul 11, 2013·The American Journal of Pathology·Nicholas Beazley-LongLucy F Donaldson
Jul 23, 2013·Nature·Xiaomeng WangJohn Greenwood
May 24, 2014·Journal of Vascular Research·Peter C StaporWalter Lee Murfee
Jan 13, 2015·Natural Product Reports·Lilibeth A Salvador-Reyes, Hendrik Luesch
May 21, 2016·Cell Chemical Biology·Anja O PaateroVille O Paavilainen
Feb 28, 2017·Investigative Ophthalmology & Visual Science·Xionggao HuangHetian Lei
Nov 24, 2015·Annual Review of Vision Science·Yoshihiko UsuiMartin Friedlander
Oct 24, 2017·ACS Medicinal Chemistry Letters·Weijing CaiHendrik Luesch

❮ Previous
Next ❯

Citations

Feb 19, 2020·Natural Product Reports·Hendrik Luesch, Ville O Paavilainen
May 14, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Lik Tong Tan, Ma Yadanar Phyo
May 18, 2021·Organic & Biomolecular Chemistry·Oliver Andler, Uli Kazmaier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.